Shmidt, T E <br/><br/>
[Dimethyl fumarate (tecfidera) is the first line treatment choice in patients with remitting multiple sclerosis].  [electronic resource] 

 -  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova   
 - 140-145 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1997-7298 
<br/><br/><label>Standard No.: </label>10.17116/jnevro2017117111140-145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dimethyl Fumarate--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy